Qube Research & Technologies (QRT)
MREO

Qube Research & Technologies (QRT)’s Mereo BioPharma MREO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-49,687
Closed -$204K – 3700
2024
Q3 		$204K Buy
49,687
+16,400
+49% +$67.8K ﹤0.01% 2580
2024
Q2 		$120K Sell
33,287
-76,040
-70% -$246K ﹤0.01% 2561
2024
Q1 		$361K Buy
109,327
+77,167
+240% +$261K ﹤0.01% 2714
2023
Q4 		$74.3K Buy
+32,160
New +$61.5K ﹤0.01% 3192
2021
Q2 		– Sell
-143,967
Closed -$485K – 2619
2021
Q1 		$485K Buy
+143,967
New +$509K 0.01% 1199

Other funds holding MREO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MREO Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of Mereo BioPharma (MREO) in Q4 2024, closing a stake of 49,687 shares — an estimated $204K sold.

Qube Research & Technologies (QRT) first reported a position in MREO in Q1 2021 and held it in 5 quarters. The position peaked at $485K in Q1 2021. 91 funds tracked by Wall St. Rank hold MREO as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining Mereo BioPharma position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 49,687 Mereo BioPharma shares in Q4 2024, an estimated $204K.
  • Qube Research & Technologies (QRT) first reported a position in Mereo BioPharma in Q1 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Mereo BioPharma position peaked at $485K in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.